Related Experiment Video
Updated: Apr 25, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Establishing a reference range for triiodothyronine levels in preterm infants
Ki Won Oh1, Mi Sung Koo2, Hye Won Park3
1Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Insights
Establishing a reference range for triiodothyronine (T3) in preterm infants is crucial. This study found T3 levels increase with gestational age, postmenstrual age, and postnatal age, aiding in normal level determination.
Area of Science:
- Neonatal endocrinology
- Pediatric thyroidology
Background:
- Thyroid dysfunction is linked to complications in preterm infants.
- Current thyroid hormone replacement lacks proven benefits due to undefined reference ranges.
Purpose of the Study:
- To establish a reference range for triiodothyronine (T3) levels at 1-month postnatal age (PNA) in preterm infants.
Main Methods:
- Retrospective analysis of thyroid function tests (TFTs) from preterm infants (gestational age <35 weeks).
- Examined relationships between T3, TSH, fT4, birth weight, GA, PMA, and PNA.
- Analyzed fT4 to T3 conversion using the T3/fT4 ratio.
Main Results:
- Analyzed 464 TFTs from 266 infants; excluded 65 with thyroid dysfunction.
- T3 levels correlated positively with fT4, birth weight, GA, PMA, and PNA, but not TSH.
- Average T3 at 1 month PNA was 72.56 ± 27.83 ng/dL, varying significantly by GA.
Conclusions:
- Low T3 and fT4 levels in preterm infants may be normal, increasing with GA, PMA, and PNA.
- The established reference range requires further study for thyroid hormone replacement therapy confirmation.
Objectives:
Thyroid dysfunction affects clinical complications in preterm infants and older children. However, thyroid hormone replacement in preterm infants has no proven benefits, possibly owing to the lack of an appropriate reference range for thyroid hormone levels. We aimed to establish a reference range for triiodothyronine (T3) levels at 1-month postnatal age (PNA) in preterm infants.
Methods:
This retrospective study included preterm infants born at a tertiary referral neonatal center at gestational age (GA)<35 weeks with no apparent thyroid dysfunction, for 6 consecutive years, with follow-up from PNA 2 weeks to 16 weeks. Using thyroid function tests (TFT), the relationships between T3 levels and thyrotropin (TSH) and free thyroxine (fT4) levels, birth weight, GA, postmenstrual age (PMA), and PNA were examined. The conversion trend for fT4 to T3 was analyzed using the T3/fT4 ratio.
Results:
Overall, 464 TFTs from 266 infants were analyzed, after excluding 65 infants with thyroid dysfunction. T3 levels increased with fT4 levels, birth weight, GA, PMA, and PNA but not with TSH levels. The T3/fT4 ratio also increased with GA, PNA, and PMA. The average T3 level at 1 month PNA was 72.56 ± 27.83 ng/dL, with significant stratifications by GA.
Conclusions:
Relatively low T3 and fT4 levels in preterm infants were considered normal, with T3 levels and conversion trends increasing with GA, PMA, and PNA. Further studies are required to confirm the role of the present reference range in thyroid hormone replacement therapy.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Hyperthyroidism I: Introduction
Therapeutic Drug Monitoring: Drug Analysis Methods
Drug Dosing: Infants and Children
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hypothyroidism II: Pathophysiology

